Area of research
Rheumatology · Nephrology
Research interest
Research interests include Systemic Lupus Erythematosus Research, Renal Diseases and Glomerulopathies, Platelet Disorders and Treatments, and Systemic Sclerosis and Related Diseases.
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey
Multistain multicompartment automatic segmentation in renal biopsies with thrombotic microangiopathies and other vasculopathies
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics
Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers
The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and <scp>InternatiOnal</scp> Networking Clinical Database and Repository
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value
From inflammation to renal fibrosis: A one-way road in autoimmunity?
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients
Differentiating between UCTD and early-stage SLE: from definitions to clinical approach
The role of antirheumatics in patients with COVID-19
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)
EULAR recommendations for a core data set for pregnancy registries in rheumatology
Characteristics of Patients With Antiphospholipid Antibody Positivity in the <scp>APS ACTION</scp> International Clinical Database and Repository
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry
16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome
Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository